Xenetic Biosciences (XBIO) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free XBIO Stock Alerts $4.04 +0.11 (+2.80%) (As of 12:18 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Xenetic Biosciences Short Interest DataCurrent Short Volume2,800 sharesPrevious Short Volume1,700 sharesChange Vs. Previous Month+64.71%Dollar Volume Sold Short$11,592.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 15, 2024Outstanding Shares1,541,000 sharesFloat Size1,250,000 sharesShort Percent of Float0.22%Today's Trading Volume1,128 sharesAverage Trading Volume5,591 sharesToday's Volume Vs. Average20% Short Selling Xenetic Biosciences ? Sign up to receive the latest short interest report for Xenetic Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXBIO Short Interest Over TimeXBIO Days to Cover Over TimeXBIO Percentage of Float Shorted Over Time Ad InvestorPlaceProof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…Go here now for full story. Xenetic Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,800 shares $11,592.00 +64.7%0.2%0.5 $4.14 3/31/20241,700 shares $6,409.00 -22.7%0.1%0.3 $3.77 3/15/20242,200 shares $9,570.00 -74.7%0.2%0.4 $4.35 2/29/20248,700 shares $36,018.00 -20.9%0.7%1.6 $4.14 2/15/202411,000 shares $39,160.00 +0.9%0.9%2.2 $3.56 1/31/202410,900 shares $40,875.00 -35.9%0.9%2.1 $3.75 Get the Latest News and Ratings for XBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenetic Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202417,000 shares $65,280.00 +71.7%1.4%3.6 $3.84 12/31/20239,900 shares $34,155.99 No Change0.8%2.3 $3.45 12/15/20239,900 shares $35,244.00 -10.8%0.8%2.4 $3.56 11/30/202311,100 shares $36,352.50 +7.8%0.9%1.9 $3.28 11/15/202310,300 shares $31,930.00 No Change0.8%1.3 $3.10 10/31/202310,300 shares $31,724.00 +17.1%0.8%1.2 $3.08 10/15/20238,800 shares $37,290.88 +3.5%0.7%1 $4.24 9/30/20238,500 shares $41,650.00 -48.2%0.6%0.5 $4.90 9/15/202316,400 shares $85,772.00 +127.8%1.2%1 $5.23 8/31/20237,200 shares $28,872.00 +67.4%0.6%0.4 $4.01 8/15/20234,300 shares $16,254.00 -39.4%0.3%0.2 $3.78 7/31/20237,100 shares $27,619.00 -78.3%0.5%0.2 $3.89 7/15/202332,700 shares $119,028.00 +52.8%2.5%1 $3.64 6/30/202321,400 shares $67,624.00 -18.6%1.6%0.7 $3.16 6/15/202326,300 shares $83,897.00 -15.2%2.0%1.1 $3.19 5/31/202331,000 shares $92,535.00 +3,775.0%2.4%1.3 $2.99 5/15/2023800 shares $0.00 -77.8%0.1%0 $0.00 4/30/202335,700 shares $14,994.00 -18.7%N/A1 $0.42 4/15/202343,900 shares $20,852.50 -11.7%N/A0.9 $0.48 3/31/202349,700 shares $20,178.20 +24.3%N/A0.9 $0.41 3/15/202340,000 shares $15,600.00 +58.1%N/A0.6 $0.39 2/28/202325,300 shares $13,156.00 -34.6%N/A0.4 $0.52 2/15/202338,700 shares $22,446.00 -61.2%N/A0.5 $0.58 1/31/202399,800 shares $71,885.94 +130.0%N/A1.3 $0.72 1/15/202343,400 shares $16,492.00 +126.0%N/A0.6 $0.38 12/30/202219,200 shares $5,473.92 -31.9%N/A0.3 $0.29 12/15/202228,200 shares $10,152.00 +3.3%N/A0.5 $0.36 11/30/202227,300 shares $12,012.00 +264.0%N/A0.6 $0.44 11/15/20227,500 shares $3,188.25 +1.4%N/A0.2 $0.43 10/31/20227,400 shares $3,469.86 -70.3%N/A0.2 $0.47 10/15/202224,900 shares $13,570.50 -22.9%0.7%0.5 $0.55 9/30/202232,300 shares $17,348.33 +74.6%1.0%0.7 $0.54 9/15/202218,500 shares $13,366.25 -66.4%0.6%0.4 $0.72 8/31/202255,000 shares $41,800.00 -6.8%1.6%1.2 $0.76Things Are Not Normal in America – Here’s What to Do (Ad)Get Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution. XBIO Short Interest - Frequently Asked Questions What is Xenetic Biosciences' current short interest? Short interest is the volume of Xenetic Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,800 shares of XBIO short. 0.22% of Xenetic Biosciences' shares are currently sold short. Learn More on Xenetic Biosciences' current short interest. What is a good short interest percentage for Xenetic Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.22% of Xenetic Biosciences' floating shares are currently sold short. Is Xenetic Biosciences' short interest increasing or decreasing? Xenetic Biosciences saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,800 shares, an increase of 64.7% from the previous total of 1,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Xenetic Biosciences' float size? Xenetic Biosciences currently has issued a total of 1,541,000 shares. Some of Xenetic Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Xenetic Biosciences currently has a public float of 1,250,000 shares. How does Xenetic Biosciences' short interest compare to its competitors? 0.22% of Xenetic Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Xenetic Biosciences: Kintara Therapeutics, Inc. (1.79%), Oragenics, Inc. (2.07%), Hoth Therapeutics, Inc. (3.39%), Adial Pharmaceuticals, Inc. (26.72%), Lixte Biotechnology Holdings, Inc. (4.59%), TFF Pharmaceuticals, Inc. (2.77%), Sonnet BioTherapeutics Holdings, Inc. (15.26%), Protagenic Therapeutics, Inc. (0.28%), Enveric Biosciences, Inc. (1.40%), Cingulate Inc. (0.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Xenetic Biosciences stock? Short selling XBIO is an investing strategy that aims to generate trading profit from Xenetic Biosciences as its price is falling. XBIO shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xenetic Biosciences? A short squeeze for Xenetic Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XBIO, which in turn drives the price of the stock up even further. How often is Xenetic Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XBIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Kintara Therapeutics Short Squeeze Oragenics Short Squeeze Hoth Therapeutics Short Squeeze Adial Pharmaceuticals Short Squeeze Lixte Biotechnology Short Squeeze TFF Pharmaceuticals Short Squeeze Sonnet BioTherapeutics Short Squeeze Protagenic Therapeutics Short Squeeze Enveric Biosciences Short Squeeze Cingulate Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XBIO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThings Are Not Normal in America – Here’s What to DoStansberry Research1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange